RE:RE:RE:RE:wannabe
If these collaborations have been going on for years, then why was there a press release about it this year?? Oh yeah! Its because these are new collaborations. The latest MD&A was the first to talk about successful collaborations with pharma partners since atleast 2017.
When liquitity comes, those 100 million shares won't know when to sell and will probably end up missing the boat. It won't take much volume to move the share price up and down. If I recall correctly, back in january, the 7 trading days after the halt and big news release saw 30 million in volume. And the price went from $1.20, to $2.87, then back to $1.65. In one week. And yes, from $1.65 the financing was at a discount, but don't be dramatic and act like they robbed you from selling at $2.87. You had basically a 2 hour window to sell up there and you missed it. It was going to come back down quick no matter what.
The shareprice is going down because people are getting impatient, its also a pretty easy stock to play when there is no news. Buy at 1.20, sell at 1.60. Same pattern all year. Once we get close to $1.20, we'll probably bounce off of support and be on our way back up for a nice little run, and then if news is timed right, bon voyage!